相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Kristine Aasebo et al.
FRONTIERS IN ONCOLOGY (2020)
A cutaneous metastasis of unresectable rectal adenocarcinoma: A case report and literature review
Riyadh Hakami et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2020)
CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma
Khadija Slik et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer
Troels Dreier Christensen et al.
ACTA ONCOLOGICA (2018)
Patterns of metastasis in colon and rectal cancer
Matias Riihimaki et al.
SCIENTIFIC REPORTS (2016)
BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression
Michael S. Landau et al.
HUMAN PATHOLOGY (2014)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer
Yoshifumi Baba et al.
CLINICAL CANCER RESEARCH (2009)
分享论文
